| ANVHX | OAZIX | ANVHX / OAZIX | |
| Total Expense Ratio | 0.97 | 0.75 | 129% |
| Annual Report Gross Expense Ratio | 0.97 | 0.75 | 129% |
| Fund Existence | 6 years | 5 years | - |
| Gain YTD | 33.208 | 23.536 | 141% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000000 | 1000000 | 500% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 546M | 14.4B | 4% |
| Annual Yield % from dividends | 2.37 | 2.23 | 106% |
| Returns for 1 year | 18.76 | 24.29 | 77% |
| Returns for 3 years | 37.85 | 38.01 | 100% |
| Returns for 5 years | 35.84 | N/A | - |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BXMX | 14.12 | 0.08 | +0.57% |
| NUVEEN S&P BUY-WRITE Income FUND | |||
| INFO | 23.82 | 0.06 | +0.23% |
| Harbor PanAgora Dynamic Lg Cp Cor ETF | |||
| IQHI | 26.12 | N/A | N/A |
| NYLI MacKay High Income ETF | |||
| CAPE | 31.47 | -0.20 | -0.62% |
| DoubleLine Shiller CAPE US Equities ETF | |||
| IBRN | 29.58 | -0.24 | -0.82% |
| iShares Neuroscience and Healthcare ETF | |||